Kansas City, MO—At the 12th annual National Organization of Rheumatology Managers conference, held September 14-16, 2017, practice managers, physician managers, and other healthcare administrators gathered to network with their peers and attend educational sessions on the future of rheumatology management in the age of value-driven healthcare.
Under the new proposed framework, the Medicare Part B therapy caps would be repealed beginning January 1, 2018. The new bipartisan agreement will continue the manual medical review process and the requirement of an appropriate modifier for claims submitted above the new threshold if procedures are considered medically necessary.
In January 2017, the AMA and 16 other healthcare organizations (Table), which represent physicians, medical groups, hospitals, pharmacists, and patients, announced that they had formed a coalition to help streamline the prior authorization process for medical tests, procedures, devices, and drugs to reduce administrative waste and save time.
Read Now
Stay up to date with rheumatology news & updates by subscribing to receive the free RPM print publications or weekly e‑Newsletter.